Barely Significant
← all excerpts

Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

BioDrugs · 2018 · PMC6290722 · PMID 30499082

Europe PMCDOI
1
hedged sentence
0.0000
closest p · 0.0× alpha
0.0000
boldest claim

The sentences

highly significantp < 0.00001actually significant
The overall effect of the combined subgroups (COI and no COI) was also highly significant for patients treated with BEVA ( p < 0.00001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.